share_log

BTIG Initiates Coverage On IDEAYA Biosciences With Buy Rating, Announces Price Target of $55

Moomoo 24/7 ·  Mar 8 09:15

BTIG analyst Justin Zelin initiates coverage on IDEAYA Biosciences (NASDAQ:IDYA) with a Buy rating and announces Price Target of $55.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment